November 3, 2026
Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions
Focused on Driving Margin Expansion
MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||
| (In millions, except per share data and percentages) | 2026 | 2025 | Change | 2026 | 2025 | Change | ||||||||||||||||
| Revenue | $ | 287.5 | $ | 250.8 | 15 | % | $ | 831.6 | $ | 729.3 | 14 | % | ||||||||||
| Gross margin | 40.7 | % | 39.5 | % | 39.6 | % | 38.7 | % | ||||||||||||||
| Operating income | $ | 20.8 | $ | 7.9 | NM | $ | 17.6 | $ | 9.8 | NM | ||||||||||||
| Operating margin | 7.2 | % | 3.1 | % | 2.1 | % | 1.3 | % | ||||||||||||||
| Net income | $ | 20.3 | $ | 7.5 | 171 | % | $ | 27.1 | $ | 17.8 | 52 | % | ||||||||||
| Earnings per diluted share | $ | 0.47 | $ | 0.18 | 161 | % | $ | 0.63 | $ | 0.42 | 50 | % | ||||||||||
| Non-GAAP Measures* | ||||||||||||||||||||||
| Adjusted gross margin | 41.0 | % | 39.8 | % | 39.9 | % | 39.2 | % | ||||||||||||||
| Adjusted EBITDA | $ | 51.5 | $ | 37.0 | 39 | % | $ | 135.2 | $ | 101.2 | 34 | % | ||||||||||
| Adjusted earnings per diluted share | $ | 0.61 | $ | 0.35 | 74 | % | $ | 1.49 | $ | 0.96 | 55 | % |
*Adjusted gross margin, adjusted EBITDA and adjusted earnings per diluted share include non-GAAP adjustments. A reconciliation from GAAP to non-GAAP metrics is provided in this earnings release.
NM - not meaningful.
Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”
Financial Highlights
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
| 2026 | 2025 | Change | 2026 | 2025 | Change | ||||||||||||
| Sales by Application | |||||||||||||||||
| Industrial Solutions | $ | 239,548 | $ | 214,697 | 12 | % | $ | 704,181 | $ | 607,593 | 16 | % | |||||
| Advanced Solutions | 47,952 | 36,095 | 33 | % | 127,396 | 121,713 | 5 | % | |||||||||
| Total | $ | 287,500 | $ | 250,792 | 15 | % | $ | 831,577 | $ | 729,306 | 14 | % |
Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.
GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.
Business Outlook and Financial Guidance
“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.
For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.
As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.
Supplemental Financial Information
Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com .
Conference Call Reminder
The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com .

